{
    "2019-12-12": [
        [
            {
                "time": "2019-01-02",
                "original_text": "Seattle Genetics' Cancer Study Boosts Prospects, Takeover Appeal",
                "features": {
                    "keywords": [
                        "Seattle Genetics",
                        "Cancer Study",
                        "Boosts Prospects",
                        "Takeover Appeal"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-03-15",
                "original_text": "AbbVie's 2019 Points to the End of the Efficient Market Thesis - Cramer",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "Efficient Market Thesis",
                        "Cramer"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-04-20",
                "original_text": "The Zacks Analyst Blog Highlights: Novartis, AbbVie, Sanofi, Pioneer Natural Resources and Aqua America",
                "features": {
                    "keywords": [
                        "Zacks Analyst Blog",
                        "Novartis",
                        "AbbVie",
                        "Sanofi",
                        "Pioneer Natural Resources",
                        "Aqua America"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "utilities",
                        "energy"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-12-12",
                "original_text": "3 Investing Facts About Required Minimum Distributions You Need to Know",
                "features": {
                    "keywords": [
                        "Investing Facts",
                        "Required Minimum Distributions"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-05-10",
                "original_text": "Should We Worry About AbbVie Inc.'s (NYSE:ABBV) P/E Ratio?",
                "features": {
                    "keywords": [
                        "AbbVie Inc.",
                        "P/E Ratio"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}